## Session overview IQ led the after-midnight gainers, rising about 11.82%, followed by Intel up roughly 9.05%, BiliBili higher by around 6.37%, AMD up approximately 5.90%, and Lam Research gaining about 4.15%. On the downside, Amgen dropped about 10.08%,

Verdict: strong AI receipts, but stretched momentum and insider selling say wait

The thesis has genuine receipts: AMD's June 2026 quarter showed revenue up 12.5% sequentially to $11.5B and net income up 66.1% to $2.3B, and per the Yahoo Finance piece the AI-driven MI450, Helios and server CPU story is the growth engine behind it. The strongest point against is that AMD insiders were net open-market sellers of roughly $153.2M across 16 holders in the ownership filing covering the period ended June 30, 2026 — the largest insider outflow on this ten-name panel — while free cash flow fell 39.3% to $1.6B despite the profit surge. As a factual scope note, this rule set could not produce an evaluable backtest window, so the decision rests on live levels and fundamentals rather than realized trade statistics. Right now the setup itself argues for patience: with the last close at $505.53 and RSI (14) at 77.12, the entry needs RSI at or below 45 and price below the 20-period EMA at $486.34 — about a 3.8% pullback. The next September-quarter SEC filing, typically late October, is the cleanest test of whether the cash-flow deterioration was a blip or a trend; a confirmed reacceleration there, combined with the price-EMA pullback, would flip this to actionable. Conviction breakdown: fundamentals trend is solid, thesis support strong, trade readiness poor because the entry conditions are unmet, and risk quality is middling given insider selling and high single-name volatility.

Trade now: AMD long setup is armed but not triggered — here's the live gap

**No entry yet.** The strategy is a long setup on AMD's 1-hour chart that needs all four conditions met at once: price below the 20-period EMA (currently 486.34 vs. a last close of 505.53), RSI (14) at or below 45 (currently 77.12), a MACD line cross above its signal line, and ADX (14) above 18 (already met at 82.95). Two conditions are close or met; the RSI condition is the binding one — momentum is running hot, roughly 32 points above the threshold. Today's action is concrete patience: set alerts at 486.34 on price and 45 on RSI, and do nothing until both are hit together with a fresh MACD cross. **Risk is defined even while you wait.** If triggered near the EMA, the plan exits at a 4.9% take-profit or a 2.5% stop, roughly a 2:1 reward-to-risk profile, with additional exits at the nearest resistance level (510.89 currently) and below the second support level (503.29 currently), plus a time stop after 292 hourly bars. Position sizing is fixed-risk at about 2.5% of the account per trade, capped at 25% of equity. **One scope note:** this rule set could not produce an evaluable backtest window in the supplied data, so no historical trade statistics are available to lean on — the decision here rests entirely on the live levels above. The idea's own session context shows AMD up about 5.90% in the after-midnight session, which explains the stretched RSI: chasing is exactly what the entry rules are designed to prevent.

Fundamental Strength Backs the Session's Big Movers

**The session's biggest gainers have fundamental receipts.** The after-midnight tape saw IQ up 11.82%, Intel up 9.05%, Bilibili up 6.37%, AMD up 5.90%, and Lam Research up 4.15% — and the underlying fundamentals for the tech names align with the move. AMD's latest quarter (period ended June 27, 2026) showed revenue of $11.5B, up 12.5% sequentially, net income up 66.1% to $2.3B, net margin expanding from 13.5% to 19.9%, and gross margin rising to 53.8%. Per the Yahoo Finance piece, AMD sees the AI boom fueling MI450, Helios, and server CPU growth — a thesis the sequential acceleration supports. **Intel's move also has a fundamental story behind it.** After a brutal 2025, Intel's June 2026 quarter showed revenue of $16.1B, up 18.8% sequentially, operating margin swinging from negative 23.1% to positive 11.1%, and free cash flow turning to a positive $4.5B from negative $2.5B the prior quarter. The Bloomberg piece citing Intel price hikes suggests the market is rewarding pricing power returning to a company that just staged one of the sharpest margin recoveries on this panel. **Bilibili's 6.37% gain fits a genuine turnaround.** FY2025 delivered revenue of $4.34B, up 18.1% year over year, a first-ever positive net margin of 3.9%, operating cash flow of $1.02B, and free cash flow of $948.7M — up 24.8% from the prior year. The trajectory from a $1.07B loss in 2021 to profitability is the kind of inflection that gets bought. **The breadth itself is signal.** Unlike the prior after-midnight session, when Lam Research's 5.12% gain led a thinner advance, this session's gainers were broader and steeper, suggesting a genuine risk-on repricing of the semiconductor and tech complex rather than a single-name idiosyncratic move. One scope note: this idea's rule set has not been evaluated in a backtest window, so the supporting argument rests on fundamentals and session context rather than realized strategy statistics.

Insiders Sold the Bounce and Amgen Shows How Fast Sentiment Flips

**Insiders were selling into this strength, not buying it.** In the ownership filings covering the period ended June 30, 2026 (the reporting deadline has passed), AMD insiders were net open-market sellers of roughly $153.2M across 16 reporting holders — by far the largest insider outflow on this panel. Lam Research insiders sold about $58.3M, Booking Holdings insiders about $25.7M, and Intel insiders about $6.5M. If the people closest to the numbers were trimming after these names' run-ups, the session's gains may partly reflect momentum chasing rather than fresh conviction. **The session's biggest loser is a warning about binary event risk.** Amgen fell 10.08% after Novartis's trial failure clouded the entire cholesterol-drug class, per the Yahoo Finance piece — a reminder that healthcare names on this list can reprice violently on one readout regardless of fundamentals. Amgen's own latest snapshot shows the pressure: Q4 2025 revenue of $9.9B against only $1.3B in net income, with a heavy debt load (debt to equity above 4, though improving). Baidu's 6.96% drop is the other side of the same coin: FY2025 showed operating margin collapsing to negative 4.5%, free cash flow of negative $2.2B, and net income down 75.5% — a fundamentally deteriorating name, not just a soft tape. **Free cash flow deterioration undercuts several of the gainers' quality.** AMD's free cash flow fell 39.3% sequentially to $1.6B in the June quarter despite the profit surge; Lam Research's FCF fell 74.1% to $1.3B and its quarterly revenue dropped 71.1% versus the prior year-period figure in the dataset, a data anomaly worth watching; Boston Scientific's quarterly net income fell 32.4% even as the stock led earlier sessions. **Volatility is the house rule here.** This session alone saw a 10-point spread between the best and worst performer, with five names down roughly 6-10%. Names on this list regularly move mid-single digits or worse in a single session — IQ, Intel, and AMD have all swung that much within days. Also note that this idea's rule set has not been evaluated in a backtest window, so there is no realized evidence base for the setup itself; the bear case leans on insider posture, the Amgen/Baidu reversals, and the persistent risk that post-midnight momentum in gainers fades by the open.

Company context

### AMD **Ownership and insiders.** For the period ending 2026-06-30, 16 reporting holders were counted holding 7282922 reported shares. Insider filings indicate net open-market selling, netting US$-153237325.37. Coverage: Deadline Passed. **Management.** Dr. Lisa T. Su Ph.D. is identified as chief executive. Dr. Lisa T. Su Ph.D. is listed as Chair, President & CEO, with reported total pay of US$4.5M for fiscal 2025. Source: [Yahoo Finance quoteSummary](https://finance.yahoo.com/quote/AMD/profile), retrieved 2026-09-09T04:14:59.71+00:00. **Dividends.** The provider's ten-year corporate-action history contains no cash dividend payments. Source: [Yahoo Finance corporate actions](https://finance.yahoo.com/quote/AMD/history?filter=div), retrieved 2026-09-09T04:14:59.71+00:00. **Fundamental changes.** Latest filed comparisons: - Debt to equity: 3.4% on 2026-06-27 versus 3.6% on 2026-03-28 (-4.1%) - Free cash flow: 1.6B on 2026-06-27 versus 2.6B on 2026-03-28 (-39.3%) - Gross margin: 53.7% on 2026-06-27 versus 52.8% on 2026-03-28 (+1.8%) - Net Income: 2.3B on 2026-06-27 versus 1.4B on 2026-03-28 (+66.1%) - Net margin: 19.9% on 2026-06-27 versus 13.4% on 2026-03-28 (+47.6%) - Operating Cash Flow: 2.4B on 2026-06-27 versus 3.0B on 2026-03-28 (-19.9%) - Operating margin: 17.2% on 2026-06-27 versus 14.3% on 2026-03-28 (+19.8%) - Revenue: 11.5B on 2026-06-27 versus 10.3B on 2026-03-28 (+12.5%) - Return on equity: 3.4% on 2026-06-27 versus 2.1% on 2026-03-28 (+59.3%) - Shares Outstanding: 1.6B on 2026-06-27 versus 1.6B on 2026-03-28 (+0.1%) Source: SEC XBRL normalized…

Scores

• Conviction score breakdown: 56
• Thesis support: 72
• Trade readiness: 35
• Risk quality: 45
• Fundamentals trend: 70

Watch items

• AMD — RSI (14), 1h
• AMD — Close vs EMA (20), 1h
• AMD — ADX (14), 1h
• AMD — Insider net open-market activity
• AMD — Free cash flow (quarterly)